Implications of baseline polymorphisms for potential resistance to NS3 protease and NS5A inhibitors in hepatitis C virus genotypes 1a, 2b and 3aShow others and affiliations
2013 (English)In: Antiviral Therapy, ISSN 1359-6535, E-ISSN 2040-2058, Vol. 18, no S1, p. A55-A55Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2013. Vol. 18, no S1, p. A55-A55
National Category
Infectious Medicine Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:uu:diva-228255ISI: 000335229500049OAI: oai:DiVA.org:uu-228255DiVA, id: diva2:733280
Conference
International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, JUN 04-08, 2013, Toronto, CANADA
2014-07-082014-07-082018-01-11Bibliographically approved